Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.61 USD | +1.36% | -0.47% | -16.41% |
04-22 | Citigroup Starts Coverage on Evolent Health With Buy Rating, $40 Price Target | MT |
03-28 | Canaccord Genuity Trims Price Target on Evolent Health to $44 From $45, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.41% | 3.12B | |
+6.64% | 32.83B | |
+19.25% | 7.73B | |
+23.82% | 3.96B | |
-19.48% | 1.38B | |
-30.77% | 1.2B | |
+8.47% | 963M | |
-32.21% | 934M | |
-28.36% | 829M | |
-17.26% | 701M |
- Stock Market
- Equities
- EVH Stock
- News Evolent Health, Inc.
- BTIG Adjusts Evolent Health's Price Target to $50 From $45, Reiterates Buy Rating